Current Statins News and Events

Current Statins News and Events, Statins News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
Important cause of preeclampsia discovered
New findings show that cholesterol crystals in the uterine wall are the villain that researchers have been looking for. These crystals cause intensified inflammation in people who become ill. (2021-01-21)

Statins may protect the heart from chemotherapy treatment of early breast cancer
Women who take statins, the common cholesterol-lowering medication, during chemotherapy with anthracyclines for early-stage breast cancer are half as likely to require emergency department visits or hospitalization for heart failure in the 5 years after chemotherapy. (2021-01-06)

Common drug may protect hearts from damage caused by breast cancer chemotherapy
New research from UHN's Peter Munk Cardiac Centre (PMCC) shows statins, commonly prescribed to lower cholesterol and reduce the risk of heart disease and stroke, may also protect the heart from damaging side-effects of early breast cancer treatment. (2021-01-06)

Fish oil supplements don't raise bad cholesterol
The Fatty Acid Research Institute (FARI) has published a new research paper in conjunction with The Cooper Institute on the omega-3s EPA and DHA in fish oil and low density lipoprotein cholesterol (LDL-C). (2020-12-17)

New in the Hastings Center Report, November-December 2020
Appealing to patient autonomy, bioethicists argue for making oral contraceptives, HIV-prevention medicines, statins, and many other prescription drugs available over the counter. (2020-12-16)

Clinical trial results address concerns about pharmacogenetic testing
Researchers conducted a randomized controlled trial of pharmacogenetic testing related to cholesterol-lowering medications called statins.After one year, the cholesterol levels in the group who received their pharmacogenetic results were not higher than those in the group who did not receive their results, and they were not less likely to receive medical care meeting recommended guidelines. (2020-12-03)

LGB adults may be less likely to take statins to prevent heart disease
Lesbian, gay and bisexual (LGB) adults are at higher risk for cardiovascular disease than non-LGB adults. Yet, LGB adults who have diabetes or high cholesterol are less likely than non-LGB adults to use statins, which help prevent cardiovascular events such as heart attacks. There is an urgent need for prevention programs aimed at reaching at-risk LGB adults to increase knowledge about the benefits of statins. (2020-12-02)

Statins can save lives, are they being used?
People who have coronary artery disease, stroke or peripheral artery disease often are prescribed a statin, a cholesterol-lowering drug that reduces the risk of heart attack or stroke. (2020-12-01)

Children with familial hypercholesterolemia are diagnosed late and under-treated
Children born with a common genetic condition, familial hypercholesterolemia (FH), are at increased risk for atherosclerotic cardiovascular disease (ASCVD) early in life. Despite long-standing national guidelines, cholesterol screening -- for children at age 2 for those with a family history of heart disease and between the ages of nine to 11 for all children -- is not being implemented . (2020-11-18)

Patients taking statins experience similar side effects from dummy pills
People taking dummy pills and statins experienced similar side effects in a new study. (2020-11-15)

Side effects often attributed to statins were the same for those taking a placebo
Study participants who reported side effects from cholesterol-lowering medications known as statins also reported the same side effects when they unknowingly took placebo pills. These side effects are real, and it appears may be mostly due to the psychological rather than the pharmacological effects of statins since symptoms were consistent when taking the placebo. (2020-11-15)

The Lancet: Older adults are at greater risk of cardiovascular events than younger people, and benefit at least as much from cholesterol-lowering medications, two studies suggest
Peer-reviewed / 1 Observational study + 1 Systematic review and meta-analysis / People (2020-11-10)

Being in treatment with statins reduces COVID-19 mortality by 22% to 25%
A research by the Universitat Rovira i Virgili (URV) and Pere Virgili Institut (IISPV) led by Lluís Masana has found that people who are being treated with statins have a 22% to 25% lower risk of dying from COVID-19. (2020-11-04)

Muscle pain and energy-rich blood: Cholesterol medicine affects the organs differently
Contrary to expectation, treatment with statins has a different effect on blood cells than on muscle cells, a new study from the University of Copenhagen reveals. Today, statins are mainly used in the treatment of elevated cholesterol, but the new results may help design drugs for a number of conditions. (2020-10-29)

Adults with endocrine disorders have an increased risk of heart disease
All adults with endocrine disorders should be tested for high cholesterol and triglycerides to evaluate their risk of heart attack or stroke, according to a Clinical Practice Guideline issued today by the Endocrine Society. (2020-10-28)

Cholesterol medications linked to lower cancer-related deaths in women
Among women with breast cancer, colorectal cancer, or melanoma, those who were taking cholesterol-lowering medications, were less likely to die from cancer, according to an analysis published in the British Journal of Clinical Pharmacology. (2020-10-21)

Statins may reduce cancer risk through mechanisms separate to cholesterol
Cholesterol-lowering drugs called statins may reduce cancer risk in humans through a pathway unrelated to cholesterol, says a study published today in eLife. (2020-10-13)

Yes or No: Forcing a choice increased statin prescribing for heart disease patients
Adding an 'active choice' nudge to the electronic health record increased statin prescribing for patients with heart disease, but not for those 'at-risk'. (2020-10-07)

Statins reduce COVID-19 severity, likely by removing cholesterol that virus uses to infect
Analyzing anonymized patient medical records, UC San Diego researchers discovered that cholesterol-lowering statins reduced risk of severe COVID-19 infection, while lab experiments uncovered a cellular mechanism that helps explain why. (2020-09-23)

COVID-19 and type 2 diabetes: do shared pathways have therapeutic implications?
During a special COVID-19 session at this year's online Annual Meeting of the European Association for the Study of Diabetes (EASD), Prof. Daniel J. Drucker (Lunenfeld Tanenbaum Research Institute, Mt. Sinai Hospital, Toronto, Canada) will present a new review of the latest clinical findings linking diabetes to risk of infection and differential outcomes in people with COVID-19 infection. (2020-09-22)

Three common medications lower risk and mortality for lung cancer
Combined use of aspirin, statins, and metformin is associated with decreased lung cancer incidence and mortality, according to a study published in the Journal of Thoracic Oncology (JTO). The JTO is the official journal of the International Association for the Study of Lung Cancer. (2020-09-17)

Generic cholesterol drugs save medicare billions of dollars, study finds
The switch from brand name to generic cholesterol medications that occurred between 2014 and 2018 has saved Medicare billions of dollars, even as the number of people on cholesterol-lowering drugs has increased, UT Southwestern scientists have calculated. Their data, published in the journal JAMA Cardiology, suggest that policymakers and clinicians could help cut Medicare costs even further by switching more patients to generic drugs. (2020-09-09)

Cholesterol drug combinations could cut health risk for European patients
More patients could benefit from combinations of cholesterol-lowering drugs to reduce their risk of stroke and heart attacks. (2020-08-28)

Food-based approach to lowering cholesterol provides significant healthcare cost savings
A new study is the first to show a food-based approach using clinically-proven diet interventions to lower cholesterol levels, such as Step One Foods®, provides significant healthcare cost savings. (2020-08-13)

Among older adults, statin use tied to decreased risk of death
A new study led by investigators from Brigham and Women's Hospital and the VA Boston Healthcare System leverages national data from the U.S. Veterans Health Administration Services and Centers for Medicare & Medicaid Services to shed new light on the role statins may play for older adults who have not yet experienced a heart attack, stroke or other cardiovascular event. (2020-07-07)

Twitter data research reveals more about what patients think about statins
More than one in seven people taking statins -- prescribed to lower cholesterol levels -- believed that meant they could still eat unhealthy foods, a new study shows. (2020-06-25)

Statin use is linked to lower death rate in hospitalized COVID-19 patients
The use of cholesterol-lowering drugs called statins is associated with a lower death rate and a lower incidence of mechanical ventilation in patients hospitalized with Coronavirus disease 2019 (COVID-19), researchers report June 24 in Cell Metabolism. The large-scale retrospective study also showed that mortality risk and other negative outcomes were not increased by combination therapy consisting of statins and blood pressure-lowering drugs called angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs). (2020-06-24)

Should nursing home residents nearing the end of life continue taking statins?
A team of researchers conducted a study to learn more about statin use among older adults, especially those nearing the end of their lives. The study, published in the Journal of the American Geriatrics Society, evaluated statin use by people with life-limiting conditions across nearly all U.S. nursing homes. The researchers hoped to identify statin use among nursing home residents who were unlikely to benefit from treatment. (2020-06-24)

New nanoparticle drug combination for atherosclerosis
Physicochemical cargo-switching nanoparticles (CSNP) designed by KAIST can help significantly reduce cholesterol and macrophage foam cells in arteries, which are the two main triggers for atherosclerotic plaque and inflammation. (2020-06-17)

Cancer patients less likely to be prescribed cardioprotective medications
As cancer survivor rates increase with modern treatments, cardiovascular disease (CVD) rates are rising in cancer patients and survivors and CVD has emerged as a leading cause of long-term preventable death in this population. Even though cardioprotective medications--including statins, ACE inhibitors and antiplatelet therapies--are frontline primary and secondary CVD prevention, patients with a prior or current history of cancer had lower rates of utilization compared to those without cancer, according to a research letter published in JACC: CardioOncology. (2020-06-16)

Improved gut microbiota with cholesterol-lowering medication
There is a clear link between improved gut microbiota and one of our most common cholesterol-lowering drug groups: statins. This is evident from a European study involving researchers from the University of Gothenburg. (2020-06-15)

The impact of disclosure laws on prescription patterns from companies that pay them
It's not uncommon for U.S. pharmaceutical companies to pay medical doctors to promote their medications. Questions over possible conflicts of interest have led to introduction of laws that require payment disclosure so that the public can see which pharmaceutical companies are paying which doctors. (2020-06-08)

Cholesterol levels dropping in Western nations -- but rising in Asia
Cholesterol levels are declining sharply in Western nations, but rising in low- and middle-income nations - particularly in Asia, suggests the largest ever study of global cholesterol levels. (2020-06-03)

Sharp drop in Australia's bad cholesterol levels -- but rising in Asia and Pacific
The proportion of Australians with bad cholesterol levels has dropped significantly, while Asian and Pacific countries recorded a sharp rise, according to the world's largest study on the condition. (2020-06-03)

Obesity is linked to gut microbiota disturbance, but not among statin-treated individuals
In 2012, the European Union MetaCardis consortium (www.MetaCardis.net), comprising 14 research groups from six European countries with multidisciplinary expertise set out to investigate a potential role of the gut microbiota in the development of cardio-metabolic diseases. This project, coordinated by Prof Karine Clément at INSERM (France) studies more than 2,000 deeply phenotyped European participants in health and at different stages of cardiometabolic disease (obesity, diabetes and cardiovascular diseases). (2020-05-06)

Cholesterol lowering drugs linked to improved gut bacteria composition in obese people
Obese Europeans who are treated with cholesterol lowering drugs have not only lower values of blood LDL cholesterol and markers of inflammation but in addition a more healthy gut bacteria profile than those obese who are not prescribed statins. This is reported in a new study in Nature by the EU-funded MetaCardis consortium. (2020-05-06)

Benefits of higher doses of certain medicines fail to justify costs and risks, study shows
Clinical trial data behind drug dose recommendations for elevated cholesterol and chronic obstructive pulmonary disease illustrate how larger doses may not be worth the extra costs for many types of patients. (2020-05-05)

Boosts in serum EPA levels from prescription fish oil drive heart benefits
Higher levels of the omega-3 fatty acid eicosapentaenoic acid (EPA) found in the blood--and not a decrease in triglyceride levels as originally thought--appear to explain the striking reductions in cardiovascular events and deaths seen among people taking 4 grams daily of the prescription fish oil, icosapent ethyl, according to findings from a REDUCE-IT substudy presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (2020-03-30)

Statins may protect against the heart harms of breast cancer therapies
Statins are widely used to lower cholesterol and prevent heart disease and related deaths, but can they also help guard against heart damage caused by certain breast cancer therapies? New research being presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC) suggests the answer may be yes. (2020-03-19)

Statins starve cancer cells to death
More than 35 million Americans take statin drugs daily to lower their blood cholesterol levels. Now, in experiments with human cells in the laboratory, researchers at Johns Hopkins Medicine have added to growing evidence that the ubiquitous drug may kill cancer cells and have uncovered clues to how they do it. (2020-03-12)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.